Clinical Trial Update: Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial of irinotecan/cisplatin with potentially curative surgery (with or without floxuridine) followed by capecitabine for gastric and GEJ cancers; stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Adenocarcinoma
• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)
• Floxuridine (floxuridine)
• Irinotecan (Irinotecan)

Snippet

Sponsor: NYU Langone Health | Conditions: Gastric Cancer, Gastric Adenocarcinoma | Phase 2 | Status: TERMINATED | Results posted: 2012-12-10